Safety and Efficacy of Rivastigmine in Patients With Alzheimer's Disease Not Responding Adequately to Donepezil: An Open-Label Study

Objective: Switching patients with Alzheimer's disease from one cholinesterase inhibitor to another represents a viable option for patients not responding to current therapy. The objective of this large U.S.-based study was to evaluate the safety and efficacy of a treatment switch to rivastigmi...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Figiel, Gary S., Sadowsky, Carl H., Strigas, John, Koumaras, Barbara, Meng, Xiangyi, Gunay, Ibrahim
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Physicians Postgraduate Press, Inc. 2008
Onderwerpen:
Original Articles
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC2528233/
https://ncbi.nlm.nih.gov/pubmed/18787673
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items